Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 352770

Celestra Inc.

Official website

Founded in 2011 and KOSDAQ-listed in 2020, Celestra develops genome-based liquid biopsy and early cancer diagnostic technologies.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2011 and listed on KOSDAQ in 2020, Celestra is a genome-based liquid biopsy and early cancer diagnostics company. It sells the CD-Prime (OPR1,000/OPR2,000) liquid biopsy platform, which simultaneously detects CTC and cfDNA from blood, more than ten genomic diagnostic tests including Geno-D, Geno-Dx, and Geno-Cancer, and cancer mutation diagnostic/monitoring products such as Cancer-Prime and Cancer-Panel. It licensed in 15 patents related to CD-PRIME from UNIST under an exclusive license (2015-2025), licensed out its Dognomics technology to Pyrico Inc. for KRW 100 million (2023-2026), and transferred RT-PCR reagent technology to AI Biotics Inc. (2022-2027, KRW 5 million upfront).

Products & technology

  • CD-Prime (OPR1,000/OPR2,000)Liquid biopsy simultaneously detecting CTC and cfDNA from blood
  • Genomic diagnostic tests (Geno-D, Geno-Dx, Geno-Cancer, and others, 10+ products)Genomic testing to predict physical traits and disease risk
  • Cancer-Prime, Cancer-PanelCancer mutation diagnosis and monitoring
  • Multi-omics based early cancer diagnostics (Cardiomics, Stressomics, etc.)Early diagnosis of major diseases including colorectal and lung cancer

R&D and key agreements

Source: DART corporate disclosure

다중오믹스 기반 조기진단(Cardiomics, Stressomics 등) · 대장암, 폐암 등 · 개발중 · Developing multi-omics (genomic and epigenomic) based early diagnostic services for major diseases including colorectal and lung cancer

Key disclosures

KRX KIND via OpenDART
Show 37 more events

Patents

KIPRIS · applicant-matched
Show 81 more patents

AI reads

MAA server logs · IP-verified
18
Times AI engines pulled Celestra Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

18
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 0
Last 7 days
13
live 0
Last 30 days
18
live 0
All time
  • OpenAIOAI-SearchBot13
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Celestra Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryMedical Devices

INTEROJO CO. LTD.100

Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.

MITECH CO.,LTD.100

MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.

JETEMA Co.,Ltd.90

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

Corentec Co., Ltd.85

Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.

NanoenTek,Inc.85

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

SEJONG MEDICAL Co.Ltd.,85

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

REMEDI Inc.85

Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.

Laseroptek Co., Ltd.85

KOSDAQ-listed medical device company developing the LOTUS and HELIOS laser aesthetic devices and the PALLAS vitiligo treatment device.

AIOBIO Co., Ltd.85

Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.

Optipharm.CO.,LTD85

Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.

LabGenomics. Co., Ltd.85

KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.

Dynamic solution Co.,Ltd.85

Founded in 2010 and KOSDAQ-listed in 2018, Dynamic Solution makes AI/IoT-based rehabilitation devices like the Rapael Smart Glove.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition